VISEN Pharmaceuticals
2561.HK News Today: Stay Updated with the Latest VISEN Pharmaceuticals News in Real Time
Find 2561.HK news now at Meyka AI. Stay informed with the latest VISEN Pharmaceuticals stocks updates, including price news, market analysis, and expert insights.
BIIB.SW Stock Drops 4.36% on April 29 as Earnings Loom
BIIB.SW stock falls 4.36% to CHF141.03 on SIX ahead of earnings. Biogen Inc. faces headwinds with declining net income and mixed technical signals.
European Stocks Advance with Earnings in Focus; Adidas Jumps on Strong Performance
European Stocks moved higher as investors closely watched fresh corporate earnings and company guidance across major sectors. Strong business updates from leading companies helped improve market sentiment, while sportswear giant Adidas stood out with a sharp rise after reporting better-than-expected performance. The positive movement in the stock market reflected growing investor confidence, especially as companies…
OSE.PA stock surges 16% on FDA orphan drug designation for VEL-101
OSE.PA jumps 16.18% to €4.25 on FDA orphan drug designation for partner Veloxis’ VEL-101 heart transplant therapy.
4568.T Daiichi Sankyo Earnings Miss EPS, Revenue Slightly Down
Daiichi Sankyo (4568.T) missed EPS estimates at $48.82 vs $55.37 expected, revenue slightly below at $587.88B vs $589.76B forecast.
4578.T Otsuka Holdings Earnings Beat: EPS Surges 36.93%
Otsuka Holdings (4578.T) crushes earnings with $186.59 EPS vs $136.27 estimate, revenue hits $633.12B. Stock up 5%.
TAK Insider Buying: Ricci Gabriele Acquires 34,994 Shares April 29, 2026
Takeda Pharmaceutical insider Ricci Gabriele acquires 34,994 American Depositary Shares as Chief Data & Tech Officer on April 27, 2026.
COPN.SW Stock Drops 5% in Pre-Market Trading on April 29
COPN.SW stock falls 5.03% to CHF86.9 in pre-market session. Cosmo Pharmaceuticals faces headwinds on SIX exchange.
IMCD.AS (IMCD N.V.) Earnings Preview April 30, 2026
IMCD N.V. earnings preview for April 30, 2026. EPS estimate $2.39, revenue estimate $1.24B. What to watch.
DOV Seaport Research Maintains Buy Rating April 2026
Seaport Global maintains Buy rating on Dover, raises price target to $265 from $245 on April 28, 2026.